UL UL
Company Profile ↓Company Overview
UL (UL) is a publicly traded company listed on with a market capitalization of $140.52B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 61.0%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 20.8%.
Trades at an undemanding P/E of 14.9.
Maintains a net profit margin of 18.8%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $50.50B (-3.8% YoY); net profit $9.47B.
- Trailing 12 Months Year-on-year growth — revenue -3.8%, earnings +64.8%.
- 5-Year Trend Long-term compounding — revenue CAGR -5.6%, profit CAGR 7.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -5.62% |
| 1 Year: | -3.77% |
Compounded Profit Growth
| 5 Years: | 7.41% |
| 1 Year: | 64.85% |
Stock Price Performance
| 1 Year: | -2.63% |
| 6 Months: | -5.21% |
| 3 Months: | +11.35% |
| 1 Month: | +2.69% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)58.17 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 61.0%.
- Healthy ROCE of 20.8%.
- Generates positive free cash flow.
CONS
- Revenue declined at -5.6% CAGR over 5 years.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 60.07B | 51.68B | 52.48B | 50.50B |
| Cost of Revenue | - | 35.91B | 29.18B | 27.98B | 26.79B |
| Gross Profit | - | 24.17B | 22.50B | 24.50B | 23.71B |
| Operating Expenses | - | 14.44B | 13.22B | 14.22B | 13.58B |
| Operating Income | - | 9.73B | 9.28B | 10.28B | 10.13B |
| EBITDA | - | 13.07B | 10.73B | 10.74B | 11.14B |
| Interest Expense | - | 789.00M | 955.00M | 999.00M | 1.10B |
| Pretax Income | - | 10.34B | 8.63B | 8.37B | 8.69B |
| Tax Provision | - | 2.07B | 1.99B | 2.33B | 2.48B |
| Net Income | - | 7.64B | 6.49B | 5.74B | 9.47B |
| Diluted EPS | - | 3.36 | 2.88 | 2.58 | 4.32 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 77.82B | 75.27B | 79.75B | 70.47B |
| Current Assets | 19.16B | 17.90B | 19.19B | 17.07B |
| Cash & Equivalents | 4.33B | 4.16B | 6.14B | 3.94B |
| Inventory | 5.93B | 5.12B | 5.18B | 4.04B |
| Receivables | 4.54B | 4.02B | 4.23B | 4.85B |
| Total Liabilities | 56.12B | 54.50B | 57.20B | 52.88B |
| Current Liabilities | 25.43B | 23.51B | 25.23B | 21.66B |
| Long Term Debt | 21.80B | 22.63B | 23.29B | 24.09B |
| Total Debt | 28.44B | 28.59B | 30.66B | 27.60B |
| Total Equity | 19.02B | 18.10B | 19.99B | 15.53B |
| Shares Outstanding | 2.34B | 2.24B | 2.24B | 2.18B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 7.28B | 9.43B | 9.52B | 8.35B |
| Investing Cash Flow | - | 2.45B | -2.29B | -625.00M | -3.12B |
| Financing Cash Flow | - | -8.89B | -7.19B | -6.94B | -6.81B |
| Capital Expenditure | - | -1.71B | -1.44B | -1.61B | -1.59B |
| Free Cash Flow | - | 5.57B | 7.99B | 7.91B | 6.76B |
| Net Change in Cash | - | 845.00M | -61.00M | 1.95B | -1.58B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 40.2% | 43.5% | 46.7% | 46.9% |
| Operating Margin % | - | 16.2% | 17.9% | 19.6% | 20.1% |
| Net Margin % | - | 12.7% | 12.6% | 10.9% | 18.7% |
| ROE % | - | 40.2% | 35.8% | 28.7% | 61.0% |
| ROCE % | - | 18.6% | 17.9% | 18.9% | 20.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for UL
Procter & Gamble to acquire Thorne for $3.8 billion, CEO says
Investing.com -- Procter & Gamble Co. reached an agreement to acquire supplement maker Thorne for $3.8 billion, with the deal set to be announced later today.
Munchkin Appoints Shaun J. Smith as Chief Revenue Officer
LOS ANGELES, August 03, 2026--Munchkin Inc. ("Munchkin" or "the Company"), the beloved baby lifestyle brand owned by WHY Brands Inc., and an industry leader in the design and development of innovative infant and toddler products, announced …
Here’s What Happened to Unilever (UL)
Fundsmith, an investment management firm based in London, has released its second-quarter 2026 investor letter for its “Fundsmith Equity Fund.” A copy of the letter can be downloaded here. The Fund returned -2.9% in the first half of 2026, …
Iran war pushes companies to raise prices on beer, paint and fries
Investing.com -- The closure of the Strait of Hormuz during the Iran war is prompting companies to raise prices on products including beer, paint, french fries and packaging as commodity and transport costs climb, the Wall Street Journal re…
Baker McKenzie leads consumer M&A law firms in H1 – data
According to GlobalData figures, Baker McKenzie was the sector’s top M&A legal adviser by volume of deals.
Unilever moves towards staff agreement ahead of McCormick deal
A Unilever spokesperson said it has “agreed commitments in Europe regarding the protection of employees’ terms and conditions and consultation timelines”.
UL — Frequently Asked Questions
What is the current share price of UL?
As of 2026-08-05 17:25 PDT, UL trades at $64.43 on NASDAQ/NYSE. Its 52-week range is $54.92 to $73.32.
What is the market capitalisation of UL?
UL has a market capitalisation of $140.52B on NASDAQ/NYSE.
What is the P/E ratio of UL?
UL trades at a trailing price-to-earnings (P/E) ratio of 14.91. Its price-to-book (P/B) ratio is 9.05.
What is the return on equity (ROE) of UL?
UL has a return on equity (ROE) of 60.97%. Its return on capital employed (ROCE) is 20.75%.
Is UL a good stock to buy?
This page provides a data-driven analysis of UL, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.